Results 231 to 240 of about 3,233,582 (249)

Intensity of and Adherence to Lipid‐Lowering Therapy as Predictors of Major Adverse Cardiovascular Outcomes in Patients With Coronary Heart Disease

Journal of the American Heart Association, 2022
Arvid Sjölander, Paul Hjemdahl, Faizan Mazhar   +2 more
exaly  

Lipid-Lowering Therapy in the Elderly

Journal of the American College of Cardiology, 2023
Christie M. Ballantyne
exaly  

Lipid-Lowering Therapy in Patients with Coronary Heart Disease and Prior Stroke: Mission Impossible?

Journal of Clinical Medicine, 2021
Pier Luigi Temporelli, Laura D'Erasmo, Raffaele De Caterina   +2 more
exaly  

Lipid Lowering Therapy, Low-Density Lipoprotein Level and Risk of Intracerebral Hemorrhage – A Meta-Analysis

Journal of Stroke and Cerebrovascular Diseases, 2019
Alberto Alvarez-Iglesias, Robert P Murphy, Michelle Canavan   +2 more
exaly  

Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011.

Journal of the American College of Cardiology, 2015
Vera Bittner, Stephen P. Glasser, Shia Kent   +2 more
exaly  

Continuation of mortality reduction after the end of randomized therapy in clinical trials of lipid-lowering therapy

Journal of Clinical Lipidology, 2011
John B Kostis, Abel Moreyra, Jerry Q Cheng   +2 more
exaly  

Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia

Atherosclerosis, 2014
José Eduardo Krieger, Letícia Camargo Tavares, Raul D Santos   +2 more
exaly  

Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice

Journal of Infection, 2004
A Clinton White, Ashok Balasubramanyam, Maria C Rodriguez-Barradas   +2 more
exaly  

Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.

Journal of the American College of Cardiology, 2008
Eugene Braunwald, Robert P Giugliano, Christopher P Cannon   +2 more
exaly  

Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy

Journal of Clinical Lipidology, 2018
Jeanine E Roeters van Lennep, Eric Sijbrands   +1 more
exaly